Polo-like kinase 2 inhibition reduces serine-129 phosphorylation of physiological nuclear alpha-synuclein but not of the aggregated alpha-synuclein.

por Sara Elfarrash, Nanna Møller Jensen, Nelson Ferreira, Sissel Ida Schmidt, Emil Gregersen, Marie Vibeke Vestergaard, Sadegh Nabavi, Morten Meyer, Poul Henning Jensen
Publicado 2021

Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease

por Luis M. A. Oliveira, Thomas Gasser, Robert Edwards, Markus Zweckstetter, Ronald Melki, Leonidas Stefanis, Hilal A. Lashuel, David Sulzer, Kostas Vekrellis, Glenda M. Halliday, Julianna J. Tomlinson, Michael Schlossmacher, Poul Henning Jensen, Julia Schulze-Hentrich, Olaf Riess, Warren D. Hirst, Omar El-Agnaf, Brit Mollenhauer, Peter Lansbury, Tiago F. Outeiro
Publicado 2021